会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • PIPERIDINE DERIVATIVES
    • 哌啶衍生物
    • WO2011101304A3
    • 2011-10-20
    • PCT/EP2011052101
    • 2011-02-14
    • HOFFMANN LA ROCHEBAUMANN KARLHEINZFLOHR ALEXANDERGOETSCHI ERWINGREEN LUKEJOLIDON SYNESEKNUST HENNERLIMBERG ANJALUEBBERS THOMASTHOMAS ANDREW
    • BAUMANN KARLHEINZFLOHR ALEXANDERGOETSCHI ERWINGREEN LUKEJOLIDON SYNESEKNUST HENNERLIMBERG ANJALUEBBERS THOMASTHOMAS ANDREW
    • C07D401/14A61K31/4523A61P25/28C07D413/14C07D417/14C07D471/04C07D487/04C07D498/04
    • C07D471/04C07D401/14C07D413/14C07D417/14C07D487/04C07D498/04
    • The invention relates to compounds of formula (I). Hetaryl I is a five or six membered heteroaryl group, containing 1 to 3 heteroatoms, selected from O, S or N; hetaryl II is a five or six membered heteroaryl group, containing 1 to 3 heteroatoms, selected from O, S or N, or is a two membered ring system containing 1 to 4 heteroatoms selected from S, O or N, wherein at least one ring is aromatic in nature; R1 is lower alkyl, lower alkoxy, lower alkyl substituted by halogen, or halogen; R2 is halogen, lower alkyl, lower alkoxy, hydroxy, lower alkyl substituted by halogen, lower alkyl substituted by hydroxy or benzo[1,3]dioxolyl, or is -(CHR)p-phenyl, optionally substituted by halogen, lower alkyl, lower alkoxy, S(O)2-lower alkyl, cyano, nitro, lower alkoxy substituted by halogen, dimethylamino, -(CH2)P-NHC(O)O-Iower alkyl, or lower alkyl substituted by halogen, and R is hydrogen, halogen, hydroxy or lower alkoxy, or is cycloalkenyl or cycloalkyl, optionally substituted by hydroxy or lower alkyl substituted by halogen, or is a five or six membered heteroaryl group, containing 1 to 3 heteroatoms, selected from O, S or N, which is optionally substituted by halogen, lower alkyl, lower alkoxy or dimethylamino, or is O-phenyl, optionally substituted by halogen, or is heterocycloalkyl, optionally substituted by halogen, hydroxy, lower alkyl substituted by halogen or C(O)O-lower alkyl; R3 is hydrogen, lower alkyl, cyano or phenyl; R4 is lower alkoxy, lower alkyl or halogen; p is 0 or 1; n is 0, 1 or 2; if n is 2 then R4 may be the same or different; m is 0, 1 or 2; if m is 2 then R1 may be the same or different; o is 0, 1, 2 or 3, if o is 2 or 3 then R2 may be the same or different; or to pharmaceutically active acid addition salts thereof. The compounds of formula (I) are modulators for amyloid beta and thus, they may be useful for the treatment or prevention of a disease associated with the deposition of ß-amyloid in the brain, in particular Alzheimer's disease, and other diseases such as cerebral amyloid angiopathy, hereditary cerebral hemorrhage with amyloidosis, Dutch-type (HCHWA-D), multi-infarct dementia, dementia pugilistica and Down syndrome.
    • 本发明涉及式(I)化合物。 芳基I是含有1至3个选自O,S或N的杂原子的五或六元杂芳基; 杂芳基II是含有1至3个选自O,S或N的杂原子的五或六元杂芳基,或是含有1至4个选自S,O或N的杂原子的二元环体系,其中至少一个环 本质上是芳香的 R1是低级烷基,低级烷氧基,被卤素取代的低级烷基或卤素; R 2为卤素,低级烷基,低级烷氧基,羟基,被卤素取代的低级烷基,被羟基或苯并[1,3]二氧杂环戊烯取代的低级烷基,或为 - (CHR)对 - 苯基,任选被卤素,低级烷基, 低级烷氧基,S(O)2-低级烷基,氰基,硝基,被卤素取代的低级烷氧基,二甲基氨基, - (CH2)P-NHC(O)O-低级烷基或被卤素取代的低级烷基,R是氢 ,卤素,羟基或低级烷氧基,或是任选被羟基或被卤素取代的低级烷基取代的环烯基或环烷基,或是含有1至3个选自O,S或N的杂原子的五或六元杂芳基,其中 或任选被卤素取代的O-苯基,或任选被卤素取代的杂环烷基,羟基,被卤素或C(O)O-低级烷基取代的低级烷基, ; R3是氢,低级烷基,氰基或苯基; R4是低级烷氧基,低级烷基或卤素; p为0或1; n为0,1或2; 如果n为2,则R4可以相同或不同; m为0,1或2; 如果m为2,则R1可以相同或不同; o为0,1,2或3,如果o为2或3,则R2可以相同或不同; 或其药物活性的酸加成盐。 式(I)化合物是淀粉样蛋白β的调节剂,因此它们可用于治疗或预防与脑中β-淀粉样蛋白沉积相关的疾病,特别是阿尔茨海默病,以及其他疾病如脑 淀粉样血管病,淀粉样变性遗传性脑出血,荷兰型(HCHWA-D),多发性梗死性痴呆,痴呆和唐氏综合征。
    • 2. 发明申请
    • MALONAMIDE DERIVATIVES
    • 马来酰胺衍生物
    • WO2006061136A2
    • 2006-06-15
    • PCT/EP2005012834
    • 2005-12-01
    • HOFFMANN LA ROCHEFLOHR ALEXANDERJAKOB-ROETNE ROLANDWOSTL WOLFGANG
    • FLOHR ALEXANDERJAKOB-ROETNE ROLANDWOSTL WOLFGANG
    • C07D267/14A61K31/553A61P25/28
    • C07D267/14C07D413/12
    • The invention relates to compounds of the general Formula (I) wherein R is halogen, lower alkyl or lower alkyl substituted by halogen; R 1 is hydrogen, lower alkyl or lower alkyl substituted by halogen or hydroxy, or is lower alkenyl, -(CH 2 ) n -cycloalkyl, -(CH 2 ) n -COR', or is benzyl, optionally substituted by halogen, or is -(CH 2 ) n -morpholinyl; R' is lower alkoxy, hydroxy or amino; R 2 is hydrogen, lower alkyl or di-lower alkyl, lower alkyl substituted by halogen or hydroxy, or is benzyl or cycloalkyl; R 3 is lower alkyl or lower alkyl substituted by halogen, or is benzyl, optionally substituted by two halogen atoms, or is -(CH 2 ) n -cycloalkyl or -(CH 2 ) n -pyridinyl; X is -CR 4 R 4 - or - CR 4 R 4' -O-; R 4 /R 4 ' is independently from each other hydrogen, halogen, lower alkyl, lower alkoxy, hydroxy or -CH 2 -2-[1,3]dioxalan-; N is 0, 1 or 2; to pharmaceutically suitable acid addition salts thereof and to all forms of optically pure enantiomers, recemates or diastereomers and diastereomeric mixtures thereof for the treatment of Alzheimer's disease.
    • 本发明涉及通式(I)的化合物,其中R是卤素,被卤素取代的低级烷基或低级烷基; R 1是氢,被卤素或羟基取代的低级烷基或低级烷基,或者是低级烯基, - (CH 2 CH 2)n - , - (CH 2 CH 2)n -COR',或是任选被卤素取代的苄基,或是 - (CH 2)2 - >名词 - 吗啉基; R'是低级烷氧基,羟基或氨基; R 2是氢,低级烷基或二低级烷基,被卤素或羟基取代的低级烷基,或是苄基或环烷基; R 3是被卤素取代的低级烷基或低级烷基,或是任选被两个卤素原子取代的苄基,或是 - (CH 2) - (CH 2)n - 亚烷基或 - (CH 2)n - X是-CR 4 S 4 - 或 - CR 4 -OR 4'-O-; R 4和R 4彼此独立地为氢,卤素,低级烷基,低级烷氧基,羟基或-CH 2 - [1,3] dioxalan-; N为0,1或2; 其药学上合适的酸加成盐和所有形式的用于治疗阿尔茨海默氏病的光学纯对映异构体,受体或非对映异构体和非对映体混合物。